ahlam1399
07-11-2016, 05:01 PM
BRIEF-Pluristem advances its U.S. FDA trial in hematologic indication
* Pluristem advances its U.S. FDA trial in hematologicindicationhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=otBtFDbtd_w:RIlEfT6Ee_A:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=otBtFDbtd_w:RIlEfT6Ee_A:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=otBtFDbtd_w:RIlEfT6Ee_A:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=otBtFDbtd_w:RIlEfT6Ee_A:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=otBtFDbtd_w:RIlEfT6Ee_A:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/otBtFDbtd_w
* Pluristem advances its U.S. FDA trial in hematologicindicationhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=otBtFDbtd_w:RIlEfT6Ee_A:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=otBtFDbtd_w:RIlEfT6Ee_A:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=otBtFDbtd_w:RIlEfT6Ee_A:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=otBtFDbtd_w:RIlEfT6Ee_A:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=otBtFDbtd_w:RIlEfT6Ee_A:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/otBtFDbtd_w